Amicus Therapeutics Inc (NASDAQ:FOLD)

12.25
Delayed Data
As of Apr 24
 -0.05 / -0.41%
Today’s Change
1.80
Today|||52-Week Range
13.20
+47.24%
Year-to-Date
No recent news for Amicus Therapeutics Inc.

Today’s Trading

Previous close12.30
Today’s open12.30
Day’s range12.16 - 12.56
Volume1,020,718
Average volume (3 months)1,760,297
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+19.83%
Earnings growth (this year)-19.89%
Earnings growth (next 5 years)--
Revenue growth (last year)+237.19%
P/E ratioNM
Price/Sales506.03
Price/Book9.58

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...-0.22-0.71%
ACHNAchillion Pharmaceut...+0.06+0.60%
PDLIPDL BioPharma Inc-0.09-1.27%
PRTAProthena Corporation...-0.48-1.27%
Data as of 4:14pm ET, 04/24/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$1.2M
Annual profit (last year)-$68.9M
Net profit margin-5,631.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers